appendix
form
part
origin
submiss
peer
review
post
suppli
author
supplement
wirtz
vj
hogerzeil
hv
gray
al
et
al
essenti
medicin
univers
health
coverag
lancet
publish
onlin
nov
http
dx
seven
dimens
element
routin
data
instagram
post
kim
kardashian
promot
morn
sick
medic
patentbas
innov
system
global
complementari
indic
critic
question
address
start
exercis
scope
sought
conform
principl
essenti
medicin
includ
efficaci
safe
costeffect
treatment
prioriti
diseas
condit
lowand
middleincom
countri
lmic
analysi
focus
medicin
administ
rel
lowresourc
health
system
without
special
care
recent
core
model
list
essenti
medicin
eml
includ
medicin
categor
use
primari
care
level
exclud
use
tertiari
care
set
secondari
care
medicin
prioriti
highburden
diseas
lmic
includ
prioriti
defin
base
current
estim
futur
public
health
relev
potenti
safe
costeffect
treatment
core
eml
includ
product
model
due
data
limit
exampl
medicin
cancer
advanc
cardiovascular
care
hepat
mani
condit
global
burden
diseas
data
use
estim
demand
medicin
complex
progress
therapi
option
base
individu
patholog
addit
sinc
product
new
limit
pastus
data
lmic
furthermor
price
product
like
chang
significantli
futur
market
nascent
evolv
addit
addit
primari
care
medicin
includ
base
nation
medicin
list
iran
south
africa
also
remov
duplic
standard
spell
includ
across
brand
gener
name
use
eml
specifi
dosag
form
strength
medicin
includ
multipl
form
strength
medicin
eml
includ
inform
refer
procur
data
kwazulunat
still
unclear
south
african
nation
depart
heath
master
procur
databas
omit
inform
pack
size
variou
list
formulari
includ
differ
pack
size
brief
analysi
reveal
consist
relationship
pack
size
unit
price
smallest
dose
unit
eg
tablet
capsul
ml
case
liquid
result
uniqu
medicin
includ
associ
dosag
form
strength
match
uniqu
medicin
list
atc
anatom
therapeut
chemic
classif
base
activ
ingredi
indic
ddd
defin
daili
dose
base
dosag
form
http
wwwwhoccnoatcdddindex
combin
medicin
ddd
compon
use
sum
analysi
medicin
without
ddd
defin
dose
unit
base
function
unit
exampl
milligram
suppositori
assum
dose
milligram
per
day
howev
data
im
health
incorpor
analysi
see
im
standard
unit
use
function
unit
describ
oral
solid
suppositori
vial
liquid
quantiti
millilitr
thu
millilitr
bottl
suspens
would
includ
dose
medicin
appli
overal
decis
rule
estim
quantiti
requir
per
medicin
first
medicin
preexist
demand
scenario
data
ie
hiv
tb
malaria
schistosomiasi
use
number
second
medicin
singl
indic
use
preval
data
estim
number
peopl
requir
treatment
lmic
lastli
medicin
ie
multipl
indic
symptom
relief
use
data
previou
consumpt
extern
group
clinton
health
access
initi
aid
medicin
diagnost
servic
unitaid
act
forecast
project
reproduct
health
suppli
coalit
stop
tb
partnership
creat
global
demand
forecast
mani
product
list
ref
ad
forecast
typic
constrainedne
project
base
fund
avail
disburs
time
scaleup
constraint
broad
term
demand
forecast
project
epidemiolog
need
given
diseas
lmic
estim
number
peopl
treatment
adjust
program
target
case
detect
constraint
could
overcom
even
unlimit
fund
patient
volum
translat
product
demand
ie
number
pill
tablet
capsul
vial
per
countri
base
standard
treatment
protocol
nationallevel
estim
aggreg
global
estim
forecast
reli
sever
assumpt
detail
appendix
exampl
assum
complet
adher
norm
guidelin
medicin
use
durat
clinic
inferior
product
therefor
assum
discontinu
strong
recommend
use
assumpt
would
violat
realworld
situat
continu
use
inferior
product
eg
stavudin
hivaid
chloroquin
malaria
global
forecast
captur
underli
need
translat
demand
forecast
base
fund
avail
scaleup
plan
health
system
relat
constraint
analysi
present
attempt
captur
demand
ideal
scenario
low
barrier
access
care
full
fund
whenev
avail
therefor
util
unconstrain
scenario
forecast
mani
case
readjust
forecast
reflect
unconstrain
need
estim
requir
purpos
studi
three
sourc
data
calcul
previou
consumpt
estim
appli
differ
analysi
scenario
see
analysi
scenario
section
first
use
combin
dataset
depot
purchas
direct
deliveri
public
sector
health
facil
kwazulunat
provinc
south
africa
decemb
novemb
dataset
thu
captur
public
sector
medicin
purchas
provinc
period
kwazulunat
kzn
data
report
quantiti
procur
per
item
item
defin
medicin
defin
strength
dosag
form
convert
milligram
base
strength
pack
size
quantiti
procur
divid
ddd
item
calcul
ddd
procur
per
year
midyear
kzn
popul
size
calcul
ddd
per
person
per
year
second
use
data
denmark
medstat
databas
http
medstatdken
includ
data
regist
medicin
product
statist
danish
state
serum
institut
medicin
sold
individu
via
pharmaci
nonpharmaci
outlet
well
primari
health
facil
hospit
use
recent
data
avail
denmark
data
report
ddd
per
peopl
per
day
arithmet
scale
ddd
per
person
per
year
report
pack
item
quantiti
litr
millilitr
per
peopl
per
day
convert
appropri
unit
price
avail
item
lastli
im
data
use
four
lmic
hungari
south
africa
thailand
turkey
data
use
countri
im
collect
data
ambulatori
hospit
channel
suppli
militari
hospit
prison
exclud
except
thailand
militari
hospit
includ
sampl
frame
data
gener
collect
sampl
basi
project
base
geographi
suppli
chain
characterist
exampl
type
specialti
size
hospit
south
africa
hospit
turkish
hospit
data
project
south
african
hospit
data
reflect
sale
inform
largest
provinc
turkey
coverag
estim
respect
inform
accuraci
audit
method
use
valid
data
found
http
wwwimshealthcomenact
im
data
collect
pack
weight
molecul
within
pack
ad
part
referenc
system
inform
togeth
calcul
standard
unit
describ
use
calcul
ddd
per
person
per
year
data
countri
use
calcul
median
upper
lower
limit
consumpt
specif
medicin
given
context
may
depend
treatment
protocol
prescrib
prefer
avail
substitut
identifi
possibl
therapeut
substitut
medicin
indic
list
base
second
third
level
therapeut
subgroup
atc
dosag
form
addit
im
data
use
comparison
ephmra
list
medicin
fall
atc
class
made
assumpt
hypothet
clinic
scenario
wherein
list
item
avail
consumpt
would
equal
sum
consumpt
substitut
medicin
use
comprehens
substitut
matrix
identifi
consumpt
substitut
convert
ddd
describ
ad
togeth
estim
total
consumpt
medicin
list
ddd
assum
report
data
cover
drug
procur
mechan
popul
could
calcul
populationbas
consumpt
directli
report
data
item
multipl
dosag
form
andor
strength
list
alloc
total
consumpt
across
form
strength
base
denmark
kzn
data
estim
proport
consumpt
per
dosag
form
per
strength
within
medicin
split
ddd
per
person
per
year
compound
accordingli
case
denmark
data
use
calcul
ddd
item
proport
alloc
also
determin
denmark
data
likewis
medicin
kzn
data
use
ddd
calcul
proport
alloc
result
ddd
per
person
per
year
uniqu
item
list
multipli
popul
lowand
middleincom
countri
calcul
much
consumpt
would
occur
countri
assum
underli
degre
pattern
consumpt
underli
dataset
multipli
ddd
item
calcul
total
milligram
consum
lowand
middleincom
countri
divid
milligram
per
unit
eg
tablet
millilitr
etc
item
obtain
estim
number
unit
need
lowand
middleincom
countri
per
year
global
burden
diseas
gbd
project
suppli
inform
number
peopl
diseasecondit
lmic
medicin
list
epidemiolog
data
gbd
conduct
extens
literatur
review
identifi
preval
point
estim
appli
estim
treatment
coverag
captur
mani
peopl
would
use
medicin
cost
model
norm
exercis
aim
estim
cost
provid
essenti
medicin
need
lowand
middleincom
countri
estim
base
level
treatment
coverag
attain
higherincom
set
see
appendix
list
treatment
coverag
estim
use
analysi
estim
treatment
coverag
use
scale
number
peopl
diseasecondit
number
would
use
relev
medicin
medicin
multipl
dosag
form
andor
strength
list
appli
process
describ
divid
across
proport
alloc
base
denmark
data
would
misrepres
kzn
data
indic
multipl
medicin
list
eg
gerd
diabet
epilepsi
standard
treatment
guidelin
identifi
first
second
third
line
treatment
option
provid
inform
split
patient
popul
across
first
second
third
line
treatment
therefor
search
literatur
inform
percentag
patient
util
pattern
appendix
includ
inform
multipli
number
peopl
would
use
uniqu
medicin
ddd
item
calcul
number
milligram
need
per
year
per
uniqu
item
medicin
list
requir
ongo
treatment
could
assum
full
year
constant
treatment
except
first
iron
defici
anaemia
variabl
treatment
durat
maintain
assumpt
simplic
second
treatment
durat
gerd
assum
person
use
medicin
requir
exactli
day
ddd
third
antivir
medicin
herp
use
either
suppress
episod
treatment
differ
daili
dose
durat
assum
patient
would
short
episod
therapi
rest
would
use
suppress
therapi
total
milligram
per
item
divid
strength
item
calcul
total
number
unit
need
medicin
list
unit
price
data
obtain
intern
drug
price
indic
guid
idpig
uniqu
product
use
supplier
median
price
unavail
use
lowest
buyer
price
idpig
idpig
report
price
given
product
calcul
unit
procur
price
base
first
kzn
procur
data
els
iran
public
sector
procur
averag
yearli
exchang
report
ir
use
convert
nation
currenc
unit
us
dollar
price
south
africa
ftc
assum
lowest
price
even
though
rsa
current
purchas
case
like
negoti
obtain
price
closer
current
ftc
price
medicin
studi
particularli
arv
singl
innov
manufactur
engag
tier
price
price
use
estim
lowest
tier
price
admittedli
countri
list
elig
lowest
tier
price
similarli
lowest
price
use
base
assumpt
gener
avail
ip
may
prevent
countri
avail
gener
price
two
main
scenario
interest
analysi
scenario
demandand
prevalencebas
quantiti
estim
describ
kept
constant
thing
chang
sourc
consumpt
data
item
use
method
quantiti
estim
scenario
data
denmark
use
estim
consumpt
per
item
ddd
medicin
proport
alloc
across
dosag
form
strength
except
medicin
would
rare
use
denmark
eg
antihelminth
would
use
differ
mani
lowandor
middleincom
set
eg
antifung
usag
would
higher
set
higher
hiv
preval
medicin
consumpt
data
kzn
use
scenario
addit
explor
two
altern
scenario
consumpt
data
replac
data
im
health
four
lmic
see
appendix
list
medicin
data
sourc
scenario
demand
forecast
data
differ
scenario
publish
base
model
preval
data
confid
interv
around
point
estim
treatment
coverag
data
set
lower
bound
higher
bound
base
case
use
best
scenario
ie
treatment
coverag
highincom
set
price
estim
unit
price
lowest
highest
price
list
idpig
markup
qualiti
assur
suppli
chain
upper
limit
markup
suppli
chain
cost
qualiti
assur
made
number
assumpt
model
exercis
first
major
assumpt
use
kzn
denmark
consumpt
data
along
substitut
matrix
clinician
patient
consist
follow
treatment
guidelin
would
randomli
distribut
across
possibl
medicin
within
therapeut
group
dosag
form
strength
assumpt
would
violat
would
impact
result
model
real
clinic
set
clinician
nonrandomli
inclin
toward
substitut
particular
particularli
high
low
price
reason
believ
might
case
made
assumpt
model
could
fulli
specifi
second
even
use
preval
data
estim
number
individu
need
treatment
unknown
mani
individu
requir
first
second
subsequ
treatment
line
assum
split
differ
line
treatment
similar
across
popul
model
take
norm
cost
approach
assum
low
barrier
access
medicin
servic
felt
confid
make
assumpt
also
conduct
literatur
review
support
assumpt
treatment
coverag
patient
divid
across
treatment
line
primarili
incorpor
data
higherincom
set
barrier
would
like
lower
third
mani
assumpt
embed
demand
forecast
use
exampl
whether
constraint
diagnosi
may
fact
lead
underestim
number
peopl
diseas
certain
histor
behavior
countri
prefer
procur
differ
tripl
fixeddos
combin
would
continu
futur
addit
assumpt
incorpor
within
arv
demand
forecast
total
number
peopl
treatment
assum
million
adult
million
children
base
countri
target
reflect
fund
commitmentavail
diagnost
scale
barrier
may
encount
still
lower
target
adult
first
line
treatment
assum
one
two
tripl
fdc
tdfftcefv
histor
procur
split
lmic
two
tripl
fdc
use
project
split
global
arv
forecast
made
base
countri
project
captur
whochaiavenir
health
document
use
estim
split
second
line
treatment
conform
recommend
assum
would
use
futur
assum
would
use
tdf
individu
use
fdc
form
singl
use
restrict
mg
strength
primarili
patient
unabl
take
fdc
need
dose
adjust
renal
impair
etc
mg
strength
assum
zero
demand
anoth
set
assumpt
use
malaria
medicin
forecast
project
number
pf
pv
case
use
forecast
develop
william
davidson
institut
base
combin
histor
wmr
case
estim
api
base
project
treatment
polici
uncompl
pf
pv
sever
malaria
countri
use
world
malaria
report
full
adher
treatment
polici
assum
estim
demand
sp
primaquin
quinin
cq
act
demand
forecast
taken
directli
forecast
develop
william
davidson
institut
act
demand
forecast
includ
three
demand
scenario
low
act
demand
moder
demand
high
demand
scenario
alreadi
includ
assumpt
greater
use
rdt
total
act
demand
split
dosesstrength
base
past
breakdown
dosesstrength
essenti
list
one
act
formul
need
split
total
act
demand
demand
individu
formul
go
assumpt
norm
estim
adher
treatment
guidelin
demand
oral
quinin
chloroquin
liquid
suspens
assum
zero
tb
medicin
forecast
also
includ
assumpt
patient
detect
pulmonari
tb
assum
put
treatment
patient
first
line
treatment
assum
standard
patient
kit
full
adher
treatment
guidelin
assum
mdrtb
split
demand
group
medicin
base
histor
split
medicin
gdf
global
fund
procur
data
feasibl
regimen
base
medicin
includ
list
follow
tabl
sourc
author
analysi
nation
health
account
nha
data
file
lancet
commiss
essenti
medicin
polici
establish
juli
commiss
charg
synthesis
lesson
learn
year
develop
implement
essenti
medicin
polici
nairobi
develop
agenda
next
year
nation
global
polici
essenti
medicin
rais
global
awar
import
essenti
medicin
polici
broader
global
health
sustain
develop
goal
especi
univers
health
coverag
defin
key
question
oper
research
contribut
increas
effect
effici
implement
essenti
medicin
polici
commission
countri
invit
person
capac
basi
technic
expertis
three
inperson
meet
held
defin
focu
work
commiss
develop
content
report
meet
commission
work
aspect
report
smaller
group
sometim
addit
research
support
event
molecul
found
conflict
categori
instanc
investig
assign
nonbiolog
includ
molecul
classifi
biolog
protect
product
protect
gener
competit
calcul
per
month
basi
countri
longer
protect
product
protect
gener
competit
countri
period
calcul
per
month
basi
countri
never
protect
product
never
protect
gener
competit
calcul
per
month
basi
countri
first
product
left
imit
product
contain
artemeth
lumefantrin
manufactur
ipca
indian
gener
compani
second
product
right
imit
coartem
also
claim
contain
artemeth
lumefantrin
imit
brand
product
produc
novarti
neither
product
contain
activ
pharmaceut
ingredi
case
packag
close
copi
genuin
product
exampl
illustr
brand
gener
product
may
target
falsif
falsif
infring
regist
trademark
also
counterfeit
incid
lahor
pakistan
kill
patient
caus
seriou
advers
reaction
other
batch
common
gener
cardiovascular
medicin
isosorbid
mononitr
test
activ
ingredi
incid
met
qualiti
specif
howev
forens
test
implic
batch
event
reveal
addit
activ
ingredi
label
product
also
contain
pyrimethamin
antimalari
medicin
substanti
overdos
effect
substanc
consist
symptom
exhibit
patient
key
reason
contamin
manufactur
neglig
disregard
good
manufactur
practic
principl
decentralis
medicin
regulatori
author
pakistan
provinci
author
made
effect
regul
challeng
gener
effect
improv
dose
hospit
mix
effect
outpati
care
uncertain
effect
improv
drug
safeti
ineffect
improv
physician
patient
outcom
mix
depend
set
outcom
patient
encount
specif
inform
provid
comput
screen
autom
order
medic
qualiti
review
relev
mix
effect
improv
appropri
care
behavior
evid
effect
prescrib
clinician
behavior
evid
patient
encounterspecif
inform
provid
verbal
paper
comput
prompt
health
profession
recal
inform
qualiti
review
relev
gener
effect
improv
appropri
care
behavior
evid
effect
improv
prescrib
gener
effect
descript
evid
base
financi
incent
chang
reimburs
incent
payment
penalti
healthcar
profession
organ
patient
qualiti
review
relev
method
payment
primari
care
physician
appear
affect
behavior
generaliz
unknown
provid
drug
budget
may
effect
improv
appropri
use
evid
pay
perform
mix
convinc
mani
set
less
half
strategi
improv
care
deliveri
overcom
system
barrier
improv
adher
strategi
improv
servic
qualiti
chang
set
care
specif
condit
mix
result
refer
price
polici
increas
use
refer
medicin
without
affect
total
use
patient
cost
share
significantli
decreas
medicin
expenditur
overal
use
effect
mix
intervent
prevent
advers
event
strategi
prevent
manag
advers
event
treatment
complic
diseas
ongo
treatment
relat
emerg
event
individu
popul
level
qualiti
review
relev
selfmonitor
self
manag
educ
decreas
anticoagul
advers
event
mix
result
asthma
epilepsi
pharmacistl
medic
qualiti
review
decreas
advers
event
pharmaci
discharg
plan
reduc
medic
error
improv
adher
effect
mix
build
skill
compet
strategi
assist
consum
develop
broad
set
compet
around
medicin
use
health
medicin
manag
monitor
train
consum
correct
use
treatment
devic
deliv
treatment
qualiti
review
relev
selfmonitor
selfmanag
skill
oral
anticoagul
haart
posit
effect
adher
mix
effect
clinic
outcom
action
plan
selfmanag
educ
diabet
cystic
fibrosi
molecul
therapeut
class
dosag
form
strength
packag
size
manufactur
distributor
product
qualiti
product
cost
payer
patient
insur
govern
longitudin
provid
inform
use
product
time
time
event
diagnosi
prescrib
dispens
outcomedeath
time
event
uniqu
patient
identifi
geograph
provid
inform
locat
use
product
nation
region
local
facil
organiz
provid
inform
set
use
product
facil
type
public
privat
formal
inform
primari
care
specialti
provid
type
characterist
cost
associ
use
product
eg
cost
test
identifi
appropri
patient
administr
fee
cold
chain
distribut
monitor
use
eg
safeti
monitor
medicin
utilis
review
cost
care
increas
offset
associ
use
product
